CMS Open Payments · Program Year 2024
Kowa Holdings America, Inc.
Kowa Holdings America, Inc. reported $3,268,628.29 across General Payments, Research, and Ownership to 0 physicians and teaching hospitals across 250 transactions.
- $3.3M Top quartile payer
- All-tracks total
- 250 Above-median volume
- Transactions
- 0 —
- Recipients
- #343
- of 1,925 companies
Kowa Holdings America, Inc. reported $3,268,628.29 across all CMS Open Payments tracks (General + Research + Ownership) to 0 physicians and teaching hospitals in Program Year 2024 - ranking #343 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total), averaging $0.00 per recipient.
Kowa Holdings America, Inc.'s payment reach score
Each tracked dimension is percentile-scored against the national companies corpus, then averaged across only the dimensions that apply to this company, a neutral scale measure of reporting activity, not a rating of quality, safety, or ethics.
Overall reach score
F
26/100
Total payments
F
40/100
Transaction volume
F
12/100
Physician reach and Payment type diversity not applicable for Kowa Holdings America, Inc. - no recorded activity on that dimension; its weight was redistributed to the applicable dimensions above.
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer kowa-holdings-america-inc Kowa Holdings America, Inc.
$3.3M · #343/1,925 · 0.0% industry · PY2024
- TOT $3.3M
- RANK #343
- SHARE 0.0%
- TXN 250
- RCP 0
- CAT 0
- GEN n/a
- PY 2024
Volume peers
Nearest volume peer: BioLineRx USA, Inc. ($3.3M)
Kowa Holdings America, Inc. sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
What the Data Shows for Kowa Holdings America, Inc.
CMS Open Payments is not a single ledger: the all-tracks total shown above is General Payments plus Research Payments plus Ownership/Investment interests, each with its own disclosure rules. For Kowa Holdings America, Inc. that figure is drawn almost entirely from the General Payments track (day-to-day consulting, meals, travel and speaking fees). Data for a given Program Year arrives roughly a year after the period it covers; our methodology page documents the release cadence and how we standardize the tracks for cross-company comparison.
The 0-category breakdown below covers general payments only (see our methodology for how research and ownership payments are reported separately). Payments are distributed across multiple categories without a dominant single type.
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Kowa Holdings America, Inc..
Showing 6 of 1,924 companies with CMS-reported payment data.
Chugai Pharmaceutical Co., Ltd.
Endo USA, Inc.
LEO Pharma Inc.
BeiGene AUS Pty Ltd
Phasor Health, LLC
Put this to use
Kowa Holdings America, Inc. ranks #343 of 1,925 by all-tracks total payments.
- See where Kowa Holdings America, Inc. sits among every top spender on the full leaderboard. Top 100 by total payments
- Compare payment categories across every manufacturer. Payment type breakdowns
- New to Open Payments? Learn what these figures do and do not show. Read the guide
Reported payments reflect what companies disclosed to CMS; a payment is not evidence of wrongdoing.
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.